Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
ImmunoCellular Therapeutics, Ltd.
ImmunoCellular Therapeutics Elects Dr. Navdeep Jaikaria to Board of Directors
July 16th, 2008
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) (IMUC), a biotechnology company, announced that Navdeep Jaikaria, Ph.D., former managing director of equity research and senior biotechnology analyst at Rodman & Renshaw, has been elected to the company's board of directors. "Dr. Jaikaria brings a wealth of knowledge to IMUC, and we are pleased in his eagerness to commit himself as a board member of IMUC as well, given that he was named one of the five best stock-pickers in biotechnology in the Wall Street Journal's annual "Best on the Street" Analysts survey in 2007," stated Manish Singh, Ph.D., president and chief executive officer of IMUC. "Navdeep is a strong addition...
Source: Vaccine Weekly (2008-07-16)
|
